These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9149557)

  • 1. 'Multidrug'-resistant tuberculosis. It is time to focus on the private sector of medicine.
    Sbarbaro JA
    Chest; 1997 May; 111(5):1149-51. PubMed ID: 9149557
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis: old lessons unlearnt?
    Bloom B; Cole S; Duncan K; Enarson D; Fine P; Ginsberg A; La Montagne J; Smith P; Young D
    Lancet; 1997 Jul; 350(9071):149. PubMed ID: 9228995
    [No Abstract]   [Full Text] [Related]  

  • 4. The threat of multidrug resistance: is tuberculosis ever untreatable or uncontrollable?
    Gleissberg V
    Lancet; 1999 Mar; 353(9157):998-9. PubMed ID: 10459924
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
    Monaldi Arch Chest Dis; 1994 Sep; 49(4):327-45. PubMed ID: 8000420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, control and treatment of multidrug-resistant tuberculosis.
    Chaulet P; Raviglione M; Bustreo F
    Drugs; 1996; 52 Suppl 2():103-7; discussion 107-8. PubMed ID: 8869846
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tuberculosis-current therapeutic principles].
    Greinert U; Zabel P
    Internist (Berl); 2003 Nov; 44(11):1394-405. PubMed ID: 14689075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis.
    Garner P; Holmes A; Ziganshina L
    Clin Evid; 2005 Dec; (14):1026-37. PubMed ID: 16620446
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin.
    Moulding TS; Le HQ; Rikleen D; Davidson P
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):743-8. PubMed ID: 15182145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis.
    Garner P; Holmes A; Ziganshina L
    Clin Evid; 2004 Jun; (11):1081-93. PubMed ID: 15652053
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding gold in the muddy waters of public health reports.
    Sbarbaro JA
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):689-90. PubMed ID: 15182137
    [No Abstract]   [Full Text] [Related]  

  • 13. Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes.
    Kritski AL; Rodrigues de Jesus LS; Andrade MK; Werneck-Barroso E; Vieira MA; Haffner A; Riley LW
    Chest; 1997 May; 111(5):1162-7. PubMed ID: 9149564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improvements in the treatment and management of control the occurrence of multidrug-resistance tuberculosis].
    Ming A
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):323-4. PubMed ID: 10374439
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment in developing countries.
    Mwinga A
    Lancet; 1995 Sep; 346(8978):812-3. PubMed ID: 7674749
    [No Abstract]   [Full Text] [Related]  

  • 17. Isoniazid-resistant tuberculosis. A community outbreak and report of a rifampin prophylaxis failure.
    Livengood JR; Sigler TG; Foster LR; Bobst JG; Snider DE
    JAMA; 1985 May; 253(19):2847-9. PubMed ID: 3989958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis.
    Koh WJ; Kwon OJ; Park YK; Lew WJ; Bai GH
    Eur Respir J; 2005 Sep; 26(3):557. PubMed ID: 16135740
    [No Abstract]   [Full Text] [Related]  

  • 20. A case series: initial outcome of persons with multidrug-resistant tuberculosis after treatment with the WHO standard retreatment regimen in Ho Chi Minh City, Vietnam.
    Lan NTN ; Lademarco MF; Binkin NJ; Tung LB; Quy HT; Cĵ NV
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):575-8. PubMed ID: 11409587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.